The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

About one third of lung transplant recipients have a genetic variant that makes them more likely to develop chronic lung ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

In the heavy-duty truck segment, Fan said methanol-hydrogen trucks show several advantages over battery electric models: ...

A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Advancing investigational pre-clinical research of APL-9099 3, a potential one-time neonatal Fc receptor (FcRn) treatment ...

Transverse colon samples from confirmed Alzheimer’s disease cases showed distinct gut microbiome and proteomic shifts, ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...

Veterans often step into ownership already equipped with the leadership toolkit many entrepreneurs spend years developing.

Based on anonymous message data from OpenAI’s platform as well as survey research, the report sought to understand how Americans are using AI for healthcare. The analysis examined billions of ChatGPT ...

How cyber, ISR and electronic warfare technologies enabled Operation Absolute Resolve and the Venezuelan president's capture, ...